ARTICLE
23 March 2022

NY HERO Act Update: COVID-19 Designation Expires

SS
Seyfarth Shaw LLP

Contributor

With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
The New York Commissioner of Health has declined to extend the designation of COVID-19 as a highly contagious communicable disease under the NY HERO Act.
United States Coronavirus (COVID-19)
To print this article, all you need is to be registered or login on Mondaq.com.

Seyfarth Synopsis: The New York Commissioner of Health has declined to extend the designation of COVID-19 as a highly contagious communicable disease under the NY HERO Act. Employers are no longer required to activate their safety plans.

As previously reported (most recently here), the New York State Commissioner of Health, on September 6, 2021, designated COVID-19 as a "highly contagious communicable disease that presents a serious risk of harm to the public health in New York State." This required employers to activate their safety plans under the NY HERO Act. Since then, the designation has been extended five times, with the latest extension set to expire on March 17, 2022.

With COVID-19 infection and hospitalization rates decreasing, and following the lifting of the HERO Act mask mandate and other preventative measures in New York (as reported here), the Health Commissioner has now allowed the designation to expire.

Thus, effective March 18, 2022, employers are no longer required to implement their Disease Exposure Prevention Plan under the HERO Act, including daily health screenings and other requirements.  Employers must continue to maintain their safety plans in the event of a later designation, but no longer need to activate them.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More